Procaps Group Sa share price today

(PROC)

Procaps Group Sa share price is $1.49 & ₹126.12 as on 6 Dec 2024, 2.30 'hrs' IST

$1.49

▲

-0.09

(-6.01%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Procaps Group Sa share price in Dollar and Rupees. Guide to invest in Procaps Group Sa from India. Also see the sentimental analysis on Indian investors investing in Procaps Group Sa. Get details on the Indian mutual funds that are investing in Procaps Group Sa. Get Analyst recommendations and forecasts along with all the Procaps Group Sa's financials.

Procaps Group Sa share price movements

$1.35
$1.59
$1.49
9.4%
Downside
Day's Volatility :15.09%
Upside
6.29%
$0.50
$4.95
$1.49
66.44%
Downside
52 Weeks Volatility :89.9%
Upside
69.9%

Procaps Group Sa Returns

Period	Procaps Group Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-23.47%	-5.7%	0.0%
6 Months	-43.54%	-0.8%	0.0%
1 Year	-52.4%	9.9%	0.0%
3 Years	-84.98%	10.7%	-19.7%

Procaps Group Sa Key Statistics

in dollars & INR

Previous Close	$1.58
Open	$1.55
Today's High	$1.59
Today's Low	$1.35
Market Capitalization	$178.3M
Today's Volume	$135.0K
52 Week High	$4.95
52 Week Low	$0.5
Revenue TTM	$414.1M
EBITDA	$57.1M
Earnings Per Share (EPS)	$0.57
PE Ratio	2.77
Profit Margin	12.61%
Quarterly Earnings Growth YOY	-0.64%
Return On Equity TTM	37.37%

How to invest in Procaps Group Sa from India?

It is very easy for Indian residents to invest directly in Procaps Group Sa from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Procaps Group Sa stock in both rupees (INR) and dollars (USD). Search for Procaps Group Sa or PROC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Procaps Group Sa or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Procaps Group Sa shares which would translate to 0.568 fractional shares of Procaps Group Sa as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Procaps Group Sa

325%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Procaps Group Sa on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 325% more investors are searching Procaps Group Sa in the last 30 days versus the previous period.

Global Institutional Holdings in Procaps Group Sa

Geode Capital Management, LLC
0.03%
Activest Wealth Management
0.01%

Analyst Recommendation on Procaps Group Sa

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Procaps Group Sa(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Procaps Group Sa

What analysts predicted

Upside of 235.57%

Current:

$1.49

Target:

$5.00

Insights on Procaps Group Sa

Increasing Revenue
Revenue is up for the last 4 quarters, 101.46M → 118.41M (in $), with an average increase of 5.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 26.95M → 8.19M (in $), with an average decrease of 34.8% per quarter
Vs CTLT
In the last 1 year, Catalent, Inc. has given 63.7% return, outperforming this stock by 114.0%
Vs NBIX
In the last 3 years, Procaps Group Sa has experienced a drawdown of -83.8%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 35.2%

Procaps Group Sa Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$324.8M	-
Net Income	$-17.0M	-
Net Profit Margin	-5.24%	-

	FY20	Y/Y Change
Revenue	$331.5M	↑ 2.06%
Net Income	$-10.4M	↓ 38.59%
Net Profit Margin	-3.15%	↑ 2.09%

	FY21	Y/Y Change
Revenue	$409.7M	↑ 23.61%
Net Income	$-100.9M	↑ 865.47%
Net Profit Margin	-24.62%	↓ 21.47%

	FY22	Y/Y Change
Revenue	$409.9M	↑ 0.04%
Net Income	$42.5M	↓ 142.18%
Net Profit Margin	10.38%	↑ 35.0%

	FY23	Y/Y Change
Revenue	$414.1M	↑ 1.02%
Net Income	$52.2M	↑ 22.72%
Net Profit Margin	12.61%	↑ 2.23%

	Q2 FY22	Q/Q Change
Revenue	$112.4M	↓ 11.16%
Net Income	$-6.9M	↓ 85.05%
Net Profit Margin	-6.15%	↑ 30.43%

	Q3 FY22	Q/Q Change
Revenue	$110.4M	↓ 1.79%
Net Income	$22.6M	↓ 426.35%
Net Profit Margin	20.45%	↑ 26.6%

	Q4 FY22	Q/Q Change
Revenue	$101.5M	↓ 8.09%
Net Income	$10.4M	↓ 53.79%
Net Profit Margin	10.28%	↓ 10.17%

	Q1 FY23	Q/Q Change
Revenue	$110.1M	↑ 8.47%
Net Income	$27.0M	↑ 158.34%
Net Profit Margin	24.49%	↑ 14.21%

	Q2 FY23	Q/Q Change
Revenue	$118.4M	↑ 7.59%
Net Income	$8.2M	↓ 69.6%
Net Profit Margin	6.92%	↓ 17.57%

	Q3 FY23	Q/Q Change
Revenue	$118.4M	↑ 0.0%
Net Income	$8.2M	↑ 0.0%
Net Profit Margin	6.92%	↑ 0.0%

	FY19	Y/Y Change
Total Assets	$337.7M	-
Total Liabilities	$581.7M	-

	FY20	Y/Y Change
Total Assets	$359.5M	↑ 6.46%
Total Liabilities	$614.2M	↑ 5.59%

	FY21	Y/Y Change
Total Assets	$462.1M	↑ 28.54%
Total Liabilities	$500.5M	↓ 18.52%

	FY22	Y/Y Change
Total Assets	$460.2M	↓ 0.42%
Total Liabilities	$462.1M	↓ 7.67%

	Q2 FY22	Q/Q Change
Total Assets	$470.2M	↑ 1.74%
Total Liabilities	$499.8M	↓ 0.14%

	Q3 FY22	Q/Q Change
Total Assets	$471.2M	↑ 0.21%
Total Liabilities	$481.7M	↓ 3.62%

	Q4 FY22	Q/Q Change
Total Assets	$84.4M	↓ 82.08%
Total Liabilities	$145.4M	↓ 69.81%

	Q1 FY23	Q/Q Change
Total Assets	$490.7M	↑ 481.2%
Total Liabilities	$458.7M	↑ 215.43%

	Q2 FY23	Q/Q Change
Total Assets	$498.6M	↑ 1.6%
Total Liabilities	$460.1M	↑ 0.31%

	Q3 FY23	Q/Q Change
Total Assets	$498.6M	↑ 0.0%
Total Liabilities	$460.1M	↑ 0.0%

	FY19	Y/Y Change
Operating Cash Flow	$68.3M	-
Investing Cash Flow	$-12.1M	-
Financing Cash Flow	$-46.9M	-

	FY20	Y/Y Change
Operating Cash Flow	$70.9M	↑ 3.86%
Investing Cash Flow	$-17.1M	↑ 41.61%
Financing Cash Flow	$-40.5M	↓ 13.72%

	Q2 FY22	Q/Q Change
Operating Cash Flow	$10.0M	↓ 61.68%
Investing Cash Flow	$-8.9M	↑ 114.28%
Financing Cash Flow	$-26.0M	↓ 55.14%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$5.8M	↓ 42.21%
Investing Cash Flow	$-7.5M	↓ 16.3%
Financing Cash Flow	$-5.4M	↓ 79.41%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 238.01%
Investing Cash Flow	$-5.0M	↓ 32.62%
Financing Cash Flow	$27.9M	↓ 620.91%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$20.4M	↓ 357.18%
Investing Cash Flow	$-5.0M	↑ 0.0%
Financing Cash Flow	$-25.0M	↓ 189.59%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$47.4M	↑ 131.98%
Investing Cash Flow	$-7.9M	↑ 56.65%
Financing Cash Flow	$-29.9M	↑ 19.44%

Procaps Group Sa Technicals Summary

Sell

Neutral

Buy

Procaps Group Sa is currently in a neutral trading position according to technical analysis indicators.

Procaps Group Sa Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procaps Group Sa	-12.65%	-43.54%	-52.4%	-84.98%	-85.44%
Neurocrine Biosciences Inc.	0.89%	-6.33%	5.35%	53.7%	11.14%
Haleon Plc Spon Ads	1.99%	14.2%	18.37%	31.31%	31.31%
Zoetis Inc.	2.58%	-1.22%	-3.88%	-22.57%	44.16%
Viatris Inc.	11.02%	23.11%	32.07%	3.95%	-21.11%
Catalent, Inc.	3.62%	10.16%	65.87%	-49.7%	19.32%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Procaps Group Sa	2.77	2.77	NA	0.0	0.37	0.06	NA	0.39
Neurocrine Biosciences Inc.	33.98	33.98	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.36	29.36	1.74	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.98	32.98	2.44	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	514.17	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procaps Group Sa	Buy	$178.3M	-85.44%	2.77	12.61%
Neurocrine Biosciences Inc.	Buy	$12.9B	11.14%	33.98	17.21%
Haleon Plc Spon Ads	Buy	$43.8B	31.31%	29.36	10.75%
Zoetis Inc.	Buy	$79.1B	44.16%	32.98	26.55%
Viatris Inc.	Hold	$15.1B	-21.11%	224.4	-5.87%
Catalent, Inc.	Hold	$11.2B	19.32%	211.02	-9.34%

About Procaps Group Sa

procaps group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. we have direct presence in 13 countries in latin america and we have more than 5,000 collaborators working under a sustainable model. we develop, manufacture, and market over-the-counter (otc) and prescription drugs, nutritional supplements and high-potential clinical solutions.

Organization	Procaps Group Sa
Employees	5500
CEO	Mr. Jose Antonio Toledo Vieira
Industry	Financial

Management People of Procaps Group Sa

Name	Title
Mr. Jose Antonio Toledo Vieira	Chief Executive Officer
Mr. Patricio Vargas Munoz	Global Chief Financial Officer
Dr. Camilo Camacho	Chief Operations Officer
Ms. Melissa Angelini	Investor Relations Director
Ms. Marcela Carvajalino Pagano	Vice-President of Corporate & Legal Affairs
Mr. Luis Alberto Palacios Aragon	Vice-President of International Marketing and R&D
Mr. Mauricio Castaneda Caballero	Vice-President of Human Resources

Important FAQs about investing in Procaps Group Sa from India :

What is Procaps Group Sa share price today?

Procaps Group Sa (PROC) share price today is $1.49.

Can Indians buy Procaps Group Sa shares?

Yes, Indians can invest in the Procaps Group Sa (PROC) from India.

With INDmoney, you can buy Procaps Group Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Procaps Group Sa at zero transaction cost.

How can I buy Procaps Group Sa shares from India?

It is very easy to buy Procaps Group Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Procaps Group Sa be purchased?

Yes, you can buy fractional shares of Procaps Group Sa with INDmoney app.

What are the documents required to start investing in Procaps Group Sa stocks?

To start investing in Procaps Group Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.